EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Maternal Cytomegalovirus Viral Load Correlates With the Risk of Congenital Infection and With Antiviral Therapy Response in Early Pregnancy

Charles Egloff, Christelle Vauloup Fellous, Nadhira Houhou-Fidouh, Alexandra Benachi, Laurent Mandelbrot iD, Alexandre J Vivanti iD, Olivier Picone

Open Forum Infectious Diseases · 02.06.2026 · 13 (6)

DOI: 10.1093/ofid/ofag291 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 24.06.2026. Verfasst von Charles Egloff und 6 weiteren Autor:innen. Beteiligte Einrichtung: Assistance Publique-Hôpitaux de Paris APHP.Nord, Service de Gynécologie Obstétrique, Hôpital Louis Mourier, Colombes, France. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To evaluate the impact of maternal cytomegalovirus (CMV) viral load at the time of intervention by valacyclovir (VCV) in preventing maternal–fetal transmission following primary CMV infection in early pregnancy and to assess the effect of VCV on maternal viral load kinetics.

Method

We conducted a retrospective, observational, dual-center study including pregnant women referred for suspected primary CMV infection during the periconceptional period or first trimester, based on serological screening performed. Primary infection was subsequently confirmed according to predefined criteria. Maternal viral load was measured by quantitative PCR on whole blood at the time of initial evaluation in the perinatal center, before treatment initiation. Patients were analyzed according to viral load status (negative, detectable, or quantifiable) and whether they received high-dose oral VCV (8 g/day). The primary outcome was congenital CMV infection, confirmed by neonatal urine PCR. Secondary outcomes included maternal viral load kinetics and their relationship to treatment.

Results

A total of 133 patients were included (90 VCV, 43 untreated). At diagnosis (median 14 weeks of gestation), 31 (24%) had negative viral load, 48 (36%) detectable, and 54 (40%) quantifiable viral load. No congenital CMV infections occurred in patients with negative viral load, regardless of treatment. Among those with quantifiable viral load, VCV was associated with lower risk of transmission compared to untreated controls (21% vs 58%; P = .028). For detectable but not quantifiable viral load, transmission rates did not differ. Longitudinally, viral load declined faster in treated patients (slope −0.3059 vs −0.1334; P = .003).

Conclusions

Maternal CMV viral load may serve as a useful prognostic indicator after primary infection in early pregnancy. Its presence could help identify a subgroup at increased risk of vertical transmission who might benefit from VCV. Conversely, negative viral load appears to be associated with a lower likelihood of fetal infection.

Schlagwörter

Stichwörter der Autor:innen

DNAemiabiomarkerscytomegaloviruspregnancyvalacyclovir

Autor:innen und Institutionen

  • Assistance Publique-Hôpitaux de Paris APHP.Nord, Service de Gynécologie Obstétrique, Hôpital Louis Mourier, Colombes, France.
  • Université Paris Cité, Paris, France.
  • Groupe de Recherche sur les Infections Pendant la Grossesse (GRIG), Velizy, France.
  • INSERM U1184, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Paris Saclay University, Fontenay-aux-Roses, France.
  • Assistance Publique-Hôpitaux de Paris, Division of Virology, Laboratoire de Biologie Médicale de Référence "Virus et Périnatalité" "Paul Brousse" Hospital, Paris Saclay University Hospitals, Villejuif, France.
  • Assistance Publique-Hôpitaux de Paris, Virology Department, Bichat Hospital, Université de Paris, Paris, France.

ORCID-Profile: Laurent Mandelbrot, Alexandre J Vivanti

Zitieren

APA

Egloff, C., Vauloup Fellous, C., Houhou-Fidouh, N., Benachi, A., Mandelbrot, L., Vivanti, A. J., & Picone, O. (2026). Maternal Cytomegalovirus Viral Load Correlates With the Risk of Congenital Infection and With Antiviral Therapy Response in Early Pregnancy. Open Forum Infectious Diseases, 13(6). https://doi.org/10.1093/ofid/ofag291

Vancouver

Egloff C, Vauloup Fellous C, Houhou-Fidouh N, Benachi A, Mandelbrot L, Vivanti AJ, et al. Maternal Cytomegalovirus Viral Load Correlates With the Risk of Congenital Infection and With Antiviral Therapy Response in Early Pregnancy. Open Forum Infectious Diseases. 2026;13(6). doi:10.1093/ofid/ofag291

BibTeX
@article{Egloff2026,
  author = {Egloff, Charles and Vauloup Fellous, Christelle and Houhou-Fidouh, Nadhira and Benachi, Alexandra and Mandelbrot, Laurent and Vivanti, Alexandre J and Picone, Olivier},
  title = {Maternal Cytomegalovirus Viral Load Correlates With the Risk of Congenital Infection and With Antiviral Therapy Response in Early Pregnancy},
  journal = {Open Forum Infectious Diseases},
  year = {2026},
  volume = {13},
  number = {6},
  doi = {10.1093/ofid/ofag291}
}
Kostenlos starten →